Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers

Completed · Phase 1

Conditions studied: Smoking Cessation

In brief

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of escalating multiple oral doses of varenicline AMT 8 controlled release formulation for 14 days in adult smokers.

Key facts

Study ID
NCT00527150
Run by
Pfizer
People needed
48
Starts
2007-10-01
Expected to finish
2008-02-01
Last updated by the study team
2010-01-11

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.